Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 265-273

  Kanazawa, Ippei ^a   Yamaguchi, Toru ^a   Yamamoto, Masahiro ^a   Yamauchi, Mika ^a   Yano, Shozo ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINO TERMINAL TELOPEPTIDE; CREATININE; HEMOGLOBIN A1C; OSTEOCALCIN; ADIPONECTIN, HUMAN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; VERTEBRA FRACTURE; BLOOD; COMPARATIVE STUDY; JAPAN; METABOLISM; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; RADIOGRAPHY; REGRESSION ANALYSIS; RISK FACTOR; SEX RATIO; SPINE FRACTURE;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BONE DENSITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; REGRESSION ANALYSIS; RISK FACTORS; SEX DISTRIBUTION; SPINAL FRACTURES;

EID: 61449206180     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0642     Document Type: Article

References (45)

1. Lim S, Joung H, Shin CS, Lee HK, Kim KS, Shin EK, Kim HY, Lim MK & Cho SI. Body composition changes with age have gender-specific impacts on bone mineral density. Bone 2004 35 792-798.
2. Felson DT, Zhang Y, Hannan MT & Anderson JJ. Effects of weight, and body mass index on bone mineral density in men and women. Journal of Bone and Mineral Research 1993 8 567-573.
3. Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE & Orwoll ES. Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. Journal of Clinical Endocrinology and Metabolism 1995 80 1118-1123.
4. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y & Matsubara K. Analysis of an expression profile of genes in the human adipose tissue. Gene 1997 190 227-235.
5. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA. Hypoadiponectemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T & Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83.
7. Combs TP, Berg AH, Obici S, Scherer PE & Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. Journal of Clinical Investigation 2001 108 1875-1881.
8. Berg AH, Combs TP, Du X, Brownlee M & Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001 7 947-953.
9. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M & Sugimoto T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biology 2007 8 51-62.
10. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U & Reseland JE. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004 35 842-849.
11. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ & Bowden DW. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003 33 646-651.
12. Richards JB, Valdes AM, Burling K, Perks UC & Spector TD. Serum adiponectin and bone mineral density in women. Journal of Clinical Endocrinology and Metabolism 2007 92 1517-1523.
13. Jürimäe J & Jürimäe T. Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporosis International 2007 18 1253-1259.
14. Jürimäe J, Rembel K, Jürimäe T & Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Hormone Metabolic Research 2005 37 297-302.
15. Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ & Liao EY. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clinica Chimica Acta 2008 387 31-35.
16. Kontogianni M, Dafni UG, Routsias J & Skopouli FN. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. Journal of Bone and Mineral Research 2004 19 546-551.
17. Huang KC, Cheng WC, Yen RF, Tsai KS, Tai TY & Yang WS. Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents. Clinical Endocrinology 2004 61 204-208.
18. Jürimäe J & Jürimäe T. Plasma adiponectin concentration in healty pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic cariables. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E42-E47.
19. Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ & Park SW. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clinical Endocrinology 2005 63 131-138.
20. Tamura T, Yoneda M, Yamane K, Nakanishi S, Nakashima R, Okubo M & Kohno N. Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism 2007 56 623-628.
21. Michaëlsson K, Lind L, Frystyk J, Flyvbjerg A, Gedeborg R, Berne C, Zethelius B, Mallmin H, Söderberg S & Melhus H. Serum adiponectin in elderly men dose not correlate with fracture risk. Journal of Clinical Endocrinology and Metabolism 2008 93 4041-4047.
22. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM & Cummings SR. Older women with diabetes have an increased risk of fracture: a prospective study. Journal of Clinical Endocrinology and Metabolism 2001 86 32-38.
23. Vestergaard P, Rejnmark L & Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005 48 1292-1299.
24. Nicodemus KK & Folsom AR. lowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001 24 1192-1197.
25. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB & Newman AB. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Archives of Internal Medicine 2005 165 1612-1617.
26. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H & Sugimoto T. Bone mineral density is not sensitive enough to assess the risk of vertebral fractures in type 2 diabetic women. Calcified Tissue International 2007 80 353-358.
27. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S & Sugimoto T. Serum insulin-like growth factor-I is associated with the presence of vertebral fractures in postmonopausal women with type 2 diabetes mellitus. Osteoporosis International 2007 18 1675-1681.
28. Yamamoto M, Yamaguchi T, Yamauchi M, Yano S & Sugimoto T. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2008 93 1013-1019.
29. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA & Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 2004 279 12152-12162.
30. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R & Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. Journal of Biological Chemistry 2003 278 40352-40363.
31. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, Heuser JE & Lodish HF. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. Journal of Biological Chemistry 2003 278 50810-50817.
32. Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D & Cummings SR. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. Journal of Bone and Mineral Research 2006 11 984-996.
33. Sugimoto T, Nishiyama K, Kuribayashi F & Chihara K. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. Journal of Bone and Mineral Research 1997 12 1272-1279.
34. Kaji H, Nomura R, Yamauchi M, Chihara K & Sugimoto T. The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism. Hormone Metabolic Research 2006 38 411-416.
35. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H & Shimomura I. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochemical and Biophysical Research Communications 2005 331 520-526.
36. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD & Liao EY. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. Journal of Bone and Mineral Research 2006 21 1648-1656.
37. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P & Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007 130 456-469.
38. Saito M, Fujii K, Mori Y & Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporosis International 2006 17 1514-1523.
39. Samelson EJ, Broe KE, Demissie S, Beck TJ, Karasik D, Kathiresan S & Kiel DP. Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip. Journal of Clinical Endocrinology and Metabolism 2008 93 1789-1795.
40. Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K & Sugimoto T. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcified Tissue International 2006 78 18-24.
41. Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G & Fukunaga M. Fracture prediction from bonemineral density in Japanese men and women. Journal of Bone and Mineral Research 2003 18 1547-1553.
42. The European Prospective Osteoporosis Study (EPOS) Group. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). Journal of Bone and Mineral Research 2002 17 716-724.
43. Van der Klift M, De Laet CE, McCloskey EV, Hofman A & Pols HA. The incidence of vertebral fractures in men and women: the Rotterdam Study. Journal of Bone and Mineral Research 2002 17 1051-1056.
44. Fujimoto WY. Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabetic Medicine 1996 13 S7-10.
45. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Kimura S, Tomita M, Kimura S, Ito C, Froguel P & Kadowaki T. Genetic cariation in the gene encoding adiponectin in associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002 51 536-540.